Home
/
Krystal Biotech, Inc.
/
Financials
/
Quarterly
Krystal Biotech, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Krystal Biotech, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$97.80M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$96.04M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$88.18M
May 6, 2025
Q3
2025
Sep 30, 2024
$83.84M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$70.28M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$45.25M
May 6, 2025
Q3
2024
Sep 30, 2023
$8.56M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$0
Aug 5, 2024
Q1
2024
Mar 31, 2023
$0
May 6, 2024
Q3
2023
Sep 30, 2022
$0
Nov 6, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$79.37M
Nov 3, 2025
Q3
2025
Jun 30, 2025
$38.33M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$38.33M
Aug 4, 2025
Q3
2025
Mar 31, 2025
$35.73M
Nov 3, 2025
Q1
2025
Mar 31, 2025
$35.73M
May 6, 2025
Q2
2025
Mar 31, 2025
$35.73M
Aug 4, 2025
Q3
2025
Sep 30, 2024
$27.18M
Nov 3, 2025
Q3
2025
Jun 30, 2024
$15.57M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$15.57M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$932.0K
May 6, 2025
Q2
2025
Mar 31, 2024
$932.0K
Aug 4, 2025
Q3
2025
Mar 31, 2024
$932.0K
Nov 3, 2025
Q3
2024
Sep 30, 2023
$80.75M
Nov 4, 2024
Q2
2024
Jun 30, 2023
($33.21M)
Aug 5, 2024
Q1
2023
Jun 30, 2023
($33.21M)
Aug 7, 2023
Q3
2024
Jun 30, 2023
($33.21M)
Nov 4, 2024
Q1
2024
Mar 31, 2023
($45.30M)
May 6, 2024
Q2
2024
Mar 31, 2023
($45.30M)
Aug 5, 2024
Q3
2024
Mar 31, 2023
($45.30M)
Nov 4, 2024
Q3
2023
Sep 30, 2022
($29.85M)
Nov 6, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$41.37M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$39.31M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$36.18M
May 6, 2025
Q3
2025
Sep 30, 2024
$22.47M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$8.57M
Aug 4, 2025
Q1
2025
Mar 31, 2024
($6.68M)
May 6, 2025
Q3
2024
Sep 30, 2023
($25.99M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($38.05M)
Aug 5, 2024
Q1
2023
Jun 30, 2023
($38.05M)
Aug 7, 2023
Q1
2024
Mar 31, 2023
($48.82M)
May 6, 2024
Q3
2023
Sep 30, 2022
($31.45M)
Nov 6, 2023
Q2
2022
Jun 30, 2022
($28.75M)
Aug 8, 2022
Q1
2023
Jun 30, 2022
($28.75M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($50.22M)
May 8, 2023
Q3
2022
Sep 30, 2021
($15.65M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($16.39M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($14.35M)
May 9, 2022
Q3
2021
Sep 30, 2020
($9.68M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($6.95M)
Aug 9, 2021
Q1
2021
Mar 31, 2020
($5.95M)
May 10, 2021